Please login to the form below

patritumab

This page shows the latest patritumab news and features for those working in and with pharma, biotech and healthcare.

Daiichi pulls study of patritumab in lung cancer

Daiichi pulls study of patritumab in lung cancer. HER3 inhibitor candidate showed no evidence of efficacy in trial analysis. ... This particular result does not directly affect the science of patritumab in other settings," said Yver.

Latest news

Daiichi Sankyo to shut down German antibody unit U3

cancer. U3 Pharma's lead candidate patritumab (U3-1287), an anti-HER3 antibody in clinical trials for non-small cell lung cancer (NSCLC), breast cancer and head and neck cancer, was

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Account Manager – Med Comms – London: Salary TBC

Senior Medical Writer: Great salary and bebefits

Project Manager, Medical Communications, London: Excellent Salary

Senior Programme Executive: Salary TBC

Medical Writer - (London, Brighton or Copenhagen): Competitive

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Scientific Director: Great salary and bebefits

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Medical Writer, e-learning/ training, London: Excellent Salary

Editorial Director – Medical Education – Oxford: Negotiable

Group Account Director, Healthcare Brand Communications, London: Excellent Package

Project Manager, Medical Communications, Oxford: Excellent Salary

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Senior Account Director, Healthcare Brand Communications, London: Excellent Package

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Senior Account Manager – Med Comms – Kent: Salary TBC

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Senior Account Manager or AD - Medical Communications: Salary TBC

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Senior Medical Writer: Great salary and benefits

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Subscribe to our email news alerts

No results were found

PMHub

Add my company

Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation: HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...